Gresham House Strategic makes its returns from applying private equity techniques to listed companies. But its strategy could also prove profitable for more traditional GPs.
The firm’s investment in soft beverages company Clearly Drinks looks set to benefit from the upcoming sugar tax.
PronoKal now has sales in excess of €42m and presence in 15 countries in Europe and Latin America, with a patient base of over 300,000 people and more than 2,500 prescribing doctors.
Real Deals attended the Impact Investing World Forum last month to gauge the latest trends from this burgeoning sector.
The firm navigated a challenging recession period and sold the tyre business to Japanese trade buyer Sumitomo for £215m this month.
Brexit loomed large over the private equity industry in 2016. It will continue to do so in 2017 and beyond.
Are Germany's gates finally opening to foreign investors?
In a year dominated by geopolitical upheaval, private equity witnessed its own turbulence in 2016 with hostile takeovers, empire building and the mega-exit of one very interesting portfolio company.
After another bumper year private equity fundraising is showing no sign of slowing down.
Even though deal value softened in 2016, secondaries investors enjoyed another strong year thanks to record war chests and narrow discounts.